ConductScience.org, home

Gene · 11213

NIH grants1,211

NIH grants whose papers are about the gene, through NIH's grant-paper links.

201 to 220 of 1,211

Download this page as JSON
GrantTitleIRAK3 papersNewest fiscal year
ZIAAI001083Studies in the Pathogenesis of Systemic Capillary Leak Syndrome12025
ZIAAI001106RNAi Screening in Hematopoietic Cells12025
ZIAAI001107Analysis of Innate Immune Signaling Networks12025
ZIAAI001157Pandemic Influenza Translational Research and novel universal countermeasure development12025
ZIACL002119Develop novel assays for assessing cellular and gene therapies12025
ZIACL009024Clinical and Molecular Features of Ebola Virus Disease12025
ZIACP010123Occupational and Environmental Determinants of Cancer among Women and Minorities12025
ZIADE000101TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance12025
ZIADE000380The role of stem cells in skeletal health and disease12025
ZIAES090057Glucocorticoid Hormone Action12025
ZIAES101965Eukaryotic Transcriptional Regulation12025
ZIAES102025Allergic sensitization through the airway12025
ZIAES102605The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury12025
ZIAHD001310Gene Regulation In The Immune System12025
ZIAHD002400The Role Of Subclinical Infection And Cytokines In Preterm Parturition12025
ZIAHG200372Genetics, Pathophysiology, and Treatment of Autoinflammatory and Autoimmune Diseases12025
ZIATR000040Toxicology in the 21st Century Program (Tox21) - Computational Toxicology12025
ZICAR041181Translational Immunology research: a support for clinical immunological research12025
ZICBC011820DNA data development for cancer cell lines and patients12025
R01AG066707Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimer’s Disease22024

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/11213/grants?page=11